Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (151-160 of 251) with videos related to

Pageof 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Cancer Research|July 8, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast TransitionGuoyu Yu, Paul G Corn, Pengfei Shen, et al.
Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Cardiovascular Drugs and Therapy|November 11, 2024
Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancerIoanna Mourkioti, Aikaterini Polyzou, Dimitris Veroutis, et al.
Pageof 26

Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Cancer Research|July 8, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast TransitionGuoyu Yu, Paul G Corn, Pengfei Shen, et al.
Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Cardiovascular Drugs and Therapy|November 11, 2024
Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancerIoanna Mourkioti, Aikaterini Polyzou, Dimitris Veroutis, et al.
Pageof 26